show episodes
 
Drs. Albert Malvehy and Todd Hansen host the VeinCast podcast for those involved in the treatment of venous and lymphatic disease. The podcast deals with topics related to vein care, practice management, new technologies and the wide range of issues physicians face practicing phlebology. Each month, a new and interesting episode will be available for download.
 
Loading …
show series
 
Guest: Paul Doghramji, MD Excessive daytime sleepiness (EDS) in obstructive sleep apnea (OSA) is frequently underrecognized, as patients may not understand the extent of their sleepiness and EDS does not always correlate with other OSA symptoms. However, it’s important for physicians to identify EDS as it may lead to adverse consequences. Dr. Paul …
 
Guest: Richard K. Bogan, MD Emerging science can help us better understand the link between obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS). While many factors, such as insufficient sleep, medication, or comorbid disorders, can cause your patients with OSA to feel sleepy, chronic sleep disruption and chronic intermittent hypoxi…
 
Host: Richard K. Bogan, MD While positive airway pressure is the standard of care treatment for obstructive sleep apnea (OSA), it may not always be enough to address the excessive daytime sleepiness (EDS) that some patients experience. In fact, in one study, up to 34 percent of patients with OSA still reported EDS (Epworth Sleepiness Score ≥10) des…
 
Host: Matt Birnholz, MD Guest: Jessica Ailani, MD What should you do if a patient uses a prescribed medication and experiences an adverse event? Here to walk us through what clinicians need to keep in mind when detecting and reporting adverse events is Dr. Jessica Ailani, Vice Chair of Strategic Planning in Medstar Georgetown Department of Neurolog…
 
Host: Jennifer Caudle, DO Guest: Victor F Tapson, MD Please see the full Prescribing Information here. This program is intended for US healthcare professionals only and is not certified for continuing medical education. Sponsored by Actelion Pharmaceuticals US, Inc., the marketer and distributor of UPTRAVI® (selexipag). Although there is currently …
 
Loading …

Quick Reference Guide

Copyright 2020 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login